Introduction: This study aims to utilize proteomics, bioinformatics, and machine learning algorithms to identify diagnostic biomarkers in the serum of patients with acute and chronic brucellosisMethods: Proteomic analysis was conducted on serum samples from patients with acute and chronic brucellosis, as well as from healthy controls. Differential expression analysis was performed to identify proteins with altered expression, while Weighted Gene Co-expression Network Analysis (WGCNA) was applied to detect co-expression modules associated with clinical features of brucellosis. Machine learning algorithms were subsequently used to identify the optimal combination of diagnostic biomarkers. Finally, ELISA was employed to validate the identified proteins.Results: A total of 1,494 differentially expressed proteins were identified, revealing two co-expression modules significantly associated with the clinical characteristics of brucellosis. The Gaussian Mixture Model (GMM) algorithm identified six proteins that were concurrently present in both the differentially expressed and co-expression modules, demonstrating promising diagnostic potential. After ELISA validation, five proteins were ultimately selected.Discussion: These five proteins are implicated in the innate immune processes of brucellosis, potentially associated with its pathogenic mechanisms and chronicity. Furthermore, we highlighted their potential as diagnostic biomarkers for brucellosis. This study further enhances our understanding of brucellosis at the protein level, paving the way for future research endeavors.
Brucellosis stands out as a severe zoonotic disease that continues to threaten public health and livestock stability. Even with vaccines currently in use, the field faces significant technical hurdles that prevent effective control. Here, we look closely at four primary directions for future development: traditional live vaccines, subunit and peptide options, and the newer, high-potential mRNA technologies. We break down how these differ regarding the immune response they trigger, their safety limits, and how well they actually protect the host. The article also highlights the essential role of animal models in testing these parameters, based on recent experimental data. Our goal is to offer a practical, scientifically grounded reference that addresses current flaws in vaccine design. Hopefully, this will speed up the move from the lab to clinical use and help solve the long-term stagnation in fighting this disease.
Objective: This study aims to explore potential biological biomarkers for brucellosis by integrating transcriptomic profiling and bioinformatics-driven approaches. Methods: Differentially expressed genes (DEGs) associated with acute and chronic brucellosis were identified using transcriptomic data from the Gene Expression Omnibus (GEO). Functional annotation and pathway enrichment analysis of DEGs were performed using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Weighted Gene Co-expression Network Analysis (WGCNA) was applied to construct gene co-expression modules, followed by screening of modules significantly correlated with disease phenotypes. Notably, a multi-model machine learning framework was employed for systematic screening, cross-validation, and validation of diagnostically relevant biomarkers—ensuring robustness and generalizability of the findings. Results: A total of 103 brucellosis patients and 46 healthy controls with whole blood transcriptomic profiles were included. Comparative analysis identified 264 DEGs, which were predominantly enriched in mitotic nuclear division, chromosome segregation, nucleocytoplasmic transport, cell cycle regulation, and cytokine-cytokine receptor interaction pathways—providing novel insights into the molecular pathogenesis of brucellosis. Immune infiltration profiling revealed that brucellosis progression was positively correlated with CD8+ T cells, follicular helper T cells, and resting NK cells—highlighting previously underappreciated immune regulatory mechanisms. Two co-expression modules were significantly associated with brucellosis clinical traits through WGCNA. Cross-validation using machine learning algorithms (LASSO, SVM, random forest) prioritized six overlapping hub genes: RTP5, KIF19, CDKN2A, RCAN2, GLB1L3, and IL12RB2. Receiver Operating Characteristic (ROC) curve analysis demonstrated robust diagnostic performance, supporting their potential as combinatorial biomarkers for brucellosis detection. Discussion: These novel hub genes are closely implicated in inflammatory responses, neutrophil regulation, and B cell receptor signaling pathways—key processes underlying brucellosis pathogenesis that have not been previously targeted for diagnostic biomarker development. This work not only enhances our understanding of brucellosis biology but also lays a critical foundation for the development of non-invasive, accurate diagnostic tools and targeted therapeutic strategies—filling a significant gap in current brucellosis management.